Falling Sick Too Often? It Could be Long COVID-19
Explore the latest breakthroughs in long COVID-19 research and treatment options to tackle lingering symptoms effectively.
Source: medindia.net
Page 2 - Nat Rev News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nat Rev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nat Rev Today - Breaking & Trending Today
Rehabilitation Through Stimulation: Exploring Noninvasive Brain Stimulation for Substance Use Disorders
In this CME article, review the current treatment modalities for noninvasive brain stimulation in the treatment of substance use disorders, and to explore the potential for further expansion of indications.
Source: psychiatrictimes.com
HIV-Associated Neurocognitive Disorder: An Updated Pathophysiology
In this CME, learn more about the pathophysiology of HIV-associated neurocognitive disorder and to review the research and various tools used to aid in the diagnosis.
Source: psychiatrictimes.com
Daily briefing: Sexism is a waste of money
Sexism harms people and is one of the biggest sources of public funding inefficiency. Plus, 12% of bird species probably driven to extinction by humans and COVID-19 vaccines lower children’s risk of long COVID. Sexism harms people and is one of the biggest sources of public funding inefficiency. Plus, 12% of bird species probably driven to extinction by humans and COVID-19 vaccines lower children’s risk of long COVID.
Source: nature.com
Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)
Ad hoc announcement pursuant to Art. 53 LR Phase III APPEAR-C3G study met its primary endpoint, demonstrating superiority of iptacopan vs. placebo in proteinuria reduction at six-month analysis1;...
Source: marketscreener.com